Retatrutide Treatment in Pembroke Pines, FL
Retatrutide Weight Loss in Pembroke Pines, FL
What is Retatrutide (Reta Peptide) and How Does It Work?
Retatrutide (sometimes called “Reta” or “Reta peptide”) is a newer, prescription injectable medication used for medical weight loss and metabolic health. It’s given as a shot under the skin, similar to other weekly weight-loss injections, and is meant to be used as part of a medically supervised plan.
Because it’s still relatively new, access and eligibility can vary. In many cases, people only receive it from a medical provider who first reviews their health history and current medications. That helps ensure it’s an appropriate option and used in a safe, structured way.
Note. Retatrutide for weight loss is still an investigational medication and is not yet approved by the U.S. Food and Drug Administration for routine clinical use. Much of the data comes from trials conducted by Eli Lilly and Company and published in or covered by The New England Journal of Medicine.
The Science: Retatrutide Triple Hormone Receptor Agonist (GGG)
Retatrutide is often called a “triple agonist” because it activates three different hormone receptors that help regulate appetite, blood sugar, and metabolism: GLP-1, GIP, and glucagon.
GLP-1 is a natural “after-meal” hormone. When GLP-1 receptors are activated, the brain gets stronger fullness signals, the stomach empties more slowly (so you stay full longer), and the pancreas releases insulin in a glucose-dependent way (more support when blood sugar is higher). That combination is a big reason GLP-1 medicines tend to reduce appetite.
GIP is another incretin hormone that also supports insulin release after meals. GIP activation may improve insulin sensitivity (how well your cells respond to insulin), which can help the body handle carbs more smoothly.
Glucagon is best known for raising blood sugar. Still, it also has effects tied to higher energy use, including supporting “calorie burn at rest” through metabolic pathways in the liver and other tissues. The idea behind pairing glucagon activity with GLP-1/GIP is to boost energy expenditure while GLP-1/GIP help keep appetite and glucose control in check.
Benefits of Retatrutide Weight Loss Injection
- Triple-Action Mechanism (GLP-1, GIP, and Glucagon). Retatrutide is designed to act on three hormone receptors involved in appetite, blood sugar regulation, and energy use.
- Substantial Weight Loss (up to 24-28% total body weight). Higher-dose groups have reported (alternate source) (alternate source 2) average retatrutide weight loss around the mid-20% range over about a year, with longer studies reporting results approaching the high-20% range. (Results vary by dose, time on retatrutide treatment, and individual factors.)
- High Success Rate (82% of patients achieve >15% weight reduction). In a 48-week study, about 83% of participants on the highest dose lost at least 15% of their starting body weight.
- Increased Energy Expenditure and Fat Metabolism. The glucagon-receptor part of the retatrutide weight loss injection is intended to increase “energy expenditure,” meaning your body may burn more calories at rest and rely more on stored energy.
- Significant Reduction in Liver Fat (up to 86%). Early studies also suggest large reductions in liver fat on imaging in some people, which is why retatrutide is being explored for metabolic conditions beyond weight.
- Improved Metabolic Markers (BP, Cholesterol, Insulin Sensitivity). Weight loss aside, researchers have reported improvements in several cardiometabolic measures (the kinds of numbers clinicians track for long-term health).
- Reduced “Food Noise” and Increased Satiety. It may help have fewer intrusive food thoughts and feel full sooner; this aligns with how GLP-1/GIP signaling influences appetite and fullness.
- Enhanced Muscle Preservation. Any significant weight loss can involve some lean-mass loss, so preserving muscle usually depends on the full plan, which typically includes adequate protein, resistance training, and close medical guidance as weight comes down.
Once-Weekly Subcutaneous Injection. In studies, retatrutide for weight loss has been given as a once-weekly injection under the skin, using a dose-escalation approach to improve tolerability.
Retatrutide vs. Other Weight Loss Medications
- Semaglutide. A GLP-1 medication. GLP-1 is a hormone signal that helps reduce appetite and increase fullness. In a large 68-week trial, people on a semaglutide injection with 2.4 mg lost an average of 14.9% of their body weight.
- Tirzepatide. A dual-action tirzepatide injection (GLP-1 + GIP). It adds a second hormone pathway that supports insulin response and metabolism. In a 72-week trial, average weight loss was about 15.0% to 20.9%, depending on dose.
- Retatrutide. A triple agonist (GLP-1 + GIP + glucagon). In a 48-week phase 2 trial, higher doses achieved average weight loss of 22.8% to 24.2%.
A plateau is common in weight loss, even with medication. As you lose weight, your body often burns fewer calories at rest (your “resting metabolic rate” drops), and your hunger signals can push back. That combination can slow progress.
Retatrutide’s “extra” piece is the glucagon receptor. In simple terms, that pathway is being explored because it may help the body use more energy, even at rest. In contrast, GLP-1 still helps with appetite control, and GIP supports insulin sensitivity. The goal of a reta peptide injection is to fight both sides of the plateau problem: appetite and energy burn.
Candidates for Retatrutide Obesity Treatment
- Adults with obesity (BMI 30+). Often considered when weight is affecting health or daily life.
- Overweight with comorbidities (BMI 27+ plus high blood pressure or high cholesterol). Commonly included in obesity medicine criteria when extra weight is tied to medical risk factors.
- Patients with weight-related conditions. Sleep apnea, osteoarthritis, and cardiovascular disease can all be impacted by excess weight.
- Individuals with metabolic dysfunction. Conditions like NAFLD/MASLD (fatty liver caused by metabolic health) or chronic kidney disease may be part of the discussion, depending on overall risk.
- People who plateaued on Wegovy or Zepbound. Some patients stop losing after early progress, and their plan may need to be adjusted under medical supervision.
- Individuals seeking non-surgical bariatric-style results. This is for people who want a strong medical option and prefer to avoid surgery, with realistic expectations.
- Those struggling with “food noise” and cravings. “Food noise” usually means constant thoughts about eating, snacking, or cravings that feel hard to shut off.
Exclusions
- Type 1 diabetes. Reta-peptide research is focused on obesity and metabolic disease and is not an insulin replacement.
- History of pancreatitis. Many programs avoid incretin-based therapies in patients with prior pancreatitis because of safety concerns.
- Personal or family history of medullary thyroid carcinoma (MTC). This is a major red flag for this medication class.
- Multiple Endocrine Neoplasia syndrome type 2 (MEN-2). Another key exclusion is tied to thyroid tumor risk.
- Recent significant weight change (more than 5 kg in the last 90 days). A big recent change can make it hard to judge baseline health and response, so many protocols pause and reassess.
- Pregnancy, breastfeeding, or planning to conceive. These medications are generally avoided during these periods for safety.
- Major cardiovascular event in the last 3 months. Recent heart attack, stroke, or similar events usually require stabilization first.
Why Choose CardioMender Wellness & Weight Loss as Your Retatrutide Clinic?
Weight loss retatrutide isn’t something we hand out after a quick chat. At our retatrutide clinic, we check your heart health before prescribing, because weight-loss treatment should support your health, not introduce new risks.
A physician will monitor you with regular follow-ups. We track how you’re doing, review side effects, and adjust your plan when needed. Retatrutide is not just a simple prescription; it requires professional medical care.
Medication is only one part of progress. We also help with nutrition and behavior changes, so your results feel steadier and more realistic. If you’re also interested in body contouring, we can discuss that too and see what fits your goals. If you’re interested in safe, supervised weight loss – contact us today!
Treatment Locations
- Aventura, FL
- Boca Raton, FL
- Broadview Park, FL
- Cooper City, FL
- Coral Gables, FL
- Coral Springs, FL
- Country Club, FL
- Cutler Bay, FL
- Davie, FL
- Delray Beach, FL
- Doral, FL
- Fern Crest Village, FL
- Fort Lauderdale, FL
- Hallandale Beach, FL
- Hialeah, FL
- Hollywood, FL
- Kendall, FL
- Key Biscayne, FL
- Lake Lucerne, FL
- Miami Beach, FL
- Miami Gardens, FL
- Miami Lakes, FL
- Miami, FL
- Miramar, FL
- North Miami Beach, FL
- North Miami, FL
- Opa-locka, FL
- Palmetto Bay, FL
- Pembroke Park, FL
- Pembroke Pines, FL
- Pinecrest, FL
- Plantation, FL
